Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Cardiovasc Comput Tomogr. 2020 Jun 21;15(2):154–160. doi: 10.1016/j.jcct.2020.06.002

Table 3.

Associations of Lp(a) levels with CAC progression*

CAC progression
1–100 U/year >100 U/year
Events/# at risk Model 1 RR (95% CI) p-value Model 2 RR (95% CI) p-value Events/# at risk Model 1 RR (95% CI) p-value Model 2 RR (95% CI) p-value
Lp(a) level
<30 mg/dL 2289/4017 1.00 1.00 255/4017 1.00 1.00
≥30 mg/dL 1069/1958 1.07 (0.93, 1.23) 0.34 1.00 (0.86, 1.16) 0.97 146/1958 1.50 (1.16, 1.92) 0.002 1.48 (1.12, 1.95) 0.005
<50 mg/dL 2716/4794 1.00 1.00 297/4794 1.00 1.00
≥50 mg/dL 642/1181 1.05 (0.92, 1.19) 0.49 1.00 (0.87, 1.15) 0.98 104/1181 1.81 (1.38, 2.39) <0.001 1.67 (1.23, 2.27) 0.001

CAC=coronary artery calcification, RR=relative risk

*

Results of multivariable relative risk regression models

Model 1 adjusted for age, sex, race, education, and clinic site

Model 2 adjusted for Model 1 + cigarette smoking, body mass index, diabetes, hypertension, family history of coronary heart disease, total cholesterol, HDL cholesterol, eGFR, hs-CRP, statin use, and aspirin use